BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 32816842)

  • 1. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
    BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer.
    Vaidya JS; Bulsara M; Saunders C; Flyger H; Tobias JS; Corica T; Massarut S; Wenz F; Pigorsch S; Alvarado M; Douek M; Eiermann W; Brew-Graves C; Williams N; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Baum M; Joseph D
    JAMA Oncol; 2020 Jul; 6(7):e200249. PubMed ID: 32239210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.
    Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Keshtgar M; Flyger HL; Massarut S; Alvarado M; Saunders C; Eiermann W; Metaxas M; Sperk E; Sütterlin M; Brown D; Esserman L; Roncadin M; Thompson A; Dewar JA; Holtveg HM; Pigorsch S; Falzon M; Harris E; Matthews A; Brew-Graves C; Potyka I; Corica T; Williams NR; Baum M;
    Lancet; 2014 Feb; 383(9917):603-13. PubMed ID: 24224997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).
    Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Saunders C; Brew-Graves C; Potyka I; Morris S; Vaidya HJ; Williams NR; Baum M
    Health Technol Assess; 2016 Sep; 20(73):1-188. PubMed ID: 27689969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger H; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Blanc-Onfroy ML; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McReady D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph D; Tobias JS
    Br J Cancer; 2021 Aug; 125(3):380-389. PubMed ID: 34035435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
    Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
    Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom.
    Vaidya A; Vaidya P; Both B; Brew-Graves C; Bulsara M; Vaidya JS
    BMJ Open; 2017 Aug; 7(8):e014944. PubMed ID: 28819067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
    Coombs NJ; Coombs JM; Vaidya UJ; Singer J; Bulsara M; Tobias JS; Wenz F; Joseph DJ; Brown DA; Rainsbury R; Davidson T; Adamson DJ; Massarut S; Morgan D; Potyka I; Corica T; Falzon M; Williams N; Baum M; Vaidya JS
    BMJ Open; 2016 May; 6(5):e010703. PubMed ID: 27160842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
    Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-center long-term results from the randomized phase-3 TARGIT-A trial comparing intraoperative and whole-breast radiation therapy for early breast cancer.
    Abo-Madyan Y; Welzel G; Sperk E; Neumaier C; Keller A; Clausen S; Schneider F; Ehmann M; Sütterlin M; Wenz F
    Strahlenther Onkol; 2019 Jul; 195(7):640-647. PubMed ID: 30796496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer.
    Sperk E; Astor D; Keller A; Welzel G; Gerhardt A; Tuschy B; Sütterlin M; Wenz F
    Radiat Oncol; 2014 Jul; 9():154. PubMed ID: 25015740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Liedtke C; Bulsara M; Vaidya JS
    Strahlenther Onkol; 2017 Jan; 193(1):62-69. PubMed ID: 27858093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy.
    Elsberger B; Romsauerova A; Vinnicombe S; Whelehan P; Brown DC; Dewar JA; Thompson AM; Evans A
    Eur J Surg Oncol; 2014 Feb; 40(2):163-7. PubMed ID: 24332581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
    Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
    Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrence.
    Kolberg HC; Niesing H; Vaidya JS; Akpolat-Basci L; Maguz A; Hoffmann O; Loevey G; Stephanou M; Kolberg-Liedtke C
    Anticancer Res; 2023 Feb; 43(2):733-739. PubMed ID: 36697057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment.
    Vaidya JS; Bulsara M; Baum M; Tobias JS;
    Br J Cancer; 2021 Apr; 124(9):1469-1474. PubMed ID: 33531693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation.
    Kolberg HC; Uhl V; Massarut S; Holmes D; Kolberg-Liedtke C; Kelly EW; Lövey G; Vaidya JS
    Anticancer Res; 2019 Aug; 39(8):4215-4218. PubMed ID: 31366508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating radiotherapy options in breast cancer: does intraoperative radiotherapy represent the most cost-efficacious option?
    Shah C; Badiyan S; Khwaja S; Shah H; Chitalia A; Nanavati A; Kundu N; Vaka V; Lanni TB; Vicini FA
    Clin Breast Cancer; 2014 Apr; 14(2):141-6. PubMed ID: 24291378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
    Welzel G; Boch A; Sperk E; Hofmann F; Kraus-Tiefenbacher U; Gerhardt A; Suetterlin M; Wenz F
    Radiat Oncol; 2013 Jan; 8():9. PubMed ID: 23294485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery.
    Alvarado MD; Conolly J; Park C; Sakata T; Mohan AJ; Harrison BL; Hayes M; Esserman LJ; Ozanne EM
    Breast Cancer Res Treat; 2014 Jan; 143(1):135-40. PubMed ID: 24292868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.